logo
Select company
Select metric
$ 28KNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
41
Sector
73
Industry
86
History
87
$ 0.51Close
$ 0.25 - $ 1.2 52-Week Range
Ticker Information

Ticker

RLYB

Company Name

RALLYBIO CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RALLYBIO CORP - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RLYB - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 28K
3/31/2025$ 5.47M
12/31/2024$ 5.47M
9/30/2024$ 5.52M
6/30/2024$ 5.52M
3/31/2024$ 282K
12/31/2023$ 282K
9/30/2023$ 51.96M
6/30/2023$ 51.98M
3/31/2023$ 51.77M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RALLYBIO CORP's latest trailing twelve months (TTM) CF - Equity stands at $ 0.
  • Over the past 5 years, RALLYBIO CORP's average CF - Equity has been $ 30.54M.
  • The median CF - Equity for RALLYBIO CORP during this period was $ 5.52M
  • RALLYBIO CORP reached its highest CF - Equity over the past 5 years at $ 86.2M.
  • The lowest CF - Equity recorded by RALLYBIO CORP in the same timeframe $ 0

RALLYBIO CORP's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
ICU : SEASTAR MEDICAL HOLDING CORP $ 18.11MLEXX : LEXARIA BIOSCIENCE CORP $ 6.05MLYRA : LYRA THERAPEUTICS INC $ 5MLSTA : LISATA THERAPEUTICS INC $ 330KSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ 7.77MPULM : PULMATRIX INC $ 0APRE : APREA THERAPEUTICS INC $ 573.98KBRTX : BIORESTORATIVE THERAPIES INC $ 2.05MIBIO : IBIO INC $ 3.67MERNA : ERNEXA THERAPEUTICS INC $ 5.93M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

RLYB - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 0

Minimum

Dec 31, 2020

$ 86.2M

Maximum

Dec 31, 2021

$ 30.54M

Average

$ 5.52M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 107.22K with a standard deviation of $ 17.65M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.89K
min$ -60.59M
max$ 60.64M
average$ 107.22K
median$ 0
std$ 17.65M